期刊文献+

我国基本药物制度实施过程中监管效率的探讨——基于成本收益分析的视角 被引量:1

The Study on the Efficiency of Government Regulation in the Essential Drug System Implementation——Based on the Perspective of the Cost-benefit Analysis
暂未订购
导出
摘要 从成本收益分析的角度,对我国基本药物制度实施过程中政府监管效率的现状进行分析,探讨提高政府监管效率的关键点,进而提出健全监管法律法规、建立有效的多部门协调机制、加快监管的信息化建设等建议,促进基本药物制度实施过程中政府监管效率的提高。 The current situation of the efficiency of government regulation in the essential medicine system implementation was analyzed using the cost-benefit analysis.The keys to the improvement of government regulation efficiency was explored in order to put forward suggestions for perfecting regulatory laws and regulations,establishing the effective multi-sectoral coordination mechanism and speeding up the information construction of regulation to promote the efficiency of government regulation for essential medicine system.
出处 《南京中医药大学学报(社会科学版)》 2012年第3期174-179,共6页 Journal of Nanjing University of Traditional Chinese Medicine(Social Science Edition)
基金 江苏省社会科学基金项目(11GLD019) 江苏省高校哲学社会科学基金项目(2011SJB630045) 江苏省教育厅高校"青蓝工程"资助项目(2008)
关键词 基本药物制度 政府监管 监管效率 成本收益分析 The essential drugs system Government regulation Efficiency of regulation Cost-benefit analysis.
  • 相关文献

参考文献12

二级参考文献47

共引文献121

同被引文献14

  • 1Ventola CL. The drug shortage crisis in the United States: causes, impact, and management strategies[J]. P T, 2011, 36(11):740-742, 749-757.
  • 2Fox E, Birt A, James K, et al. ASHP guidelines on managing drug product shortages in hospitals and health systems[J]. Am J Health Syst Pharm, 2009, 66( 15): 1399-1406.
  • 3Kaakeh R, Sweet BV, Reilly C, et al. Impact of drug shortages on U.S. health systems[J]. Am J Health Syst Pharm, 2011, 68(19):1811-1819.
  • 4Johnson TJ. Drug shortages: an increasing problem for patients and clinicians[J]. S D Med, 2011, 64(1):14-15.
  • 5FDA. Drug approvals and databases [EB/OL]. (2014-10- 20). http://www.fda, gov/Drugs/Infor- mation On Drugs/ default.htm.
  • 6RoyA.FDA+医保价格管制=药物短缺[N].徐树明,译.医药经济报,2012-06-20(9).
  • 7US. President's Fiscal Year 2014 Budget Request for the FDA [EB/OL]. (2013-04--26). http://www.fda.gov/NewsEvents/ Testimony/ucm351980.htm.
  • 8张翠莲,梅丹,李大魁.我国应对部分药品短缺的策略初探[J].中国药房,2009,20(25):1933-1936. 被引量:10
  • 9田昕,宋雅然,张新平.以系统理论分析国家基本药物制度[J].中国卫生事业管理,2010,27(4):243-245. 被引量:8
  • 10刘敏豪,邬倩倩.我国基本药物短缺问题研究[J].中国药房,2012,23(8):673-674. 被引量:12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部